Back

tugMedi: simulator of cancer-cell evolution for personalized medicine based on the genomic data of patients

Nagornov, I.; Furukawa, E.; Nagai, M.; Yagishita, S.; Shibata, T.; Kato, M.

2025-07-03 bioinformatics
10.1101/2025.06.27.661855 bioRxiv
Show abstract

Cancer comprehensive genomic profiling tests are increasingly used, but drug response rates remain limited. Simulations forecasting cancer progression could aid targeted therapies; however, existing simulations focus mainly on basic biology. We present tugMedi, a cancer-cell evolution simulator designed for cancer genome medicine. By integrating patient-specific genomic and imaging data, tugMedi reconstructs each tumors genomic features and growth behavior, enabling real-time predictions of clonal dynamics under virtual drug regimens. tugMedi explicitly models copy number alterations and SNVs on parental chromosomes in recessive and dominant modes, capturing loss-of-heterozygosity and yielding precise variant allele frequencies and tumor contents. It handles mutations in cancer-related genes with real exon-intron structures by a fast algorithm. For TCGA samples, it provided ensemble predictions of clonal dynamics, allowing extraction of drug response, tumor-size shrinkage rates, and time to recurrence under specific drug conditions. tugMedi represents a first step toward simulation-driven genome medicine based on a patient-derived virtual tumor.

Published in npj Systems Biology and Applications (predicted rank #29) · training set

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.